# CRF Implementation - Gap Analysis

**Checked Against**: KC MeSempa RWE Study - Case Record Form (Word Document)

---

## ✅ FULLY IMPLEMENTED (All Fields Present)

### SECTION A – PATIENT IDENTIFICATION
- ✅ Patient Code
- ✅ Study Site / Clinic Code (studySiteCode)
- ✅ Investigator Name
- ✅ Date of Baseline Visit

### SECTION B – DEMOGRAPHICS & LIFESTYLE
- ✅ Age (years)
- ✅ Gender (Male/Female/Other)
- ✅ Height (cm)
- ✅ Weight (kg)
- ✅ BMI (kg/m²)
- ✅ Smoking status (Never/Former/Current)
- ✅ Alcohol intake (No/Occasional/Regular)
- ✅ Physical activity level (Sedentary/Moderate/Active)

### SECTION C – DIABETES HISTORY & PHENOTYPE
- ✅ Duration of Type 2 Diabetes (years)
- ✅ Baseline Glycemic Severity (HbA1c <7.5% / 7.5–8.5% / 8.6–10% / >10%)
- ✅ Diabetes-Related Complications (Neuropathy/Retinopathy/Nephropathy/CAD/Stroke/None)

### SECTION D – COMORBIDITIES
- ✅ Hypertension
- ✅ Dyslipidemia
- ✅ Obesity
- ✅ ASCVD
- ✅ Heart Failure
- ✅ Chronic Kidney Disease
- ✅ Other (free text)
- ✅ If CKD present – baseline eGFR category (≥90 / 60–89 / 45–59 / 30–44)

### SECTION E – PRIOR ANTI-DIABETIC THERAPY
- ✅ Previous Treatment Type (Drug-naïve/Oral only/Insulin only/Oral + Insulin)
- ✅ Previously used drug classes (Metformin/Sulfonylurea/DPP-4/SGLT-2/TZD/Insulin)
- ✅ Reason for initiating KC MeSempa (all 7 options + Other)

### SECTION F – BASELINE CLINICAL & LAB PARAMETERS (WEEK 0)
- ✅ HbA1c (%)
- ✅ Fasting Plasma Glucose (mg/dL)
- ✅ Post-Prandial Glucose (mg/dL)
- ✅ Blood Pressure (Systolic/Diastolic in mmHg)
- ✅ Heart Rate (bpm)
- ✅ Serum Creatinine (mg/dL)
- ✅ eGFR (mL/min/1.73 m²)
- ✅ Urinalysis (Normal/Abnormal with specification)

### SECTION G – TREATMENT & COUNSELLING (BASELINE)
- ✅ KC MeSempa dose prescribed
- ✅ Date of initiation
- ✅ Counselling provided:
  - ✅ Diet & lifestyle
  - ✅ Hypoglycemia awareness
  - ✅ UTI / genital infection awareness
  - ✅ Hydration advice

### SECTION H – FOLLOW-UP CLINICAL & LAB PARAMETERS (WEEK 12 ± 2 WEEKS)
- ✅ HbA1c (%)
- ✅ Fasting Plasma Glucose (mg/dL)
- ✅ Post-Prandial Glucose (mg/dL)
- ✅ Weight (kg)
- ✅ Blood Pressure (Systolic/Diastolic in mmHg)
- ✅ Serum Creatinine (mg/dL)
- ✅ eGFR (mL/min/1.73 m²)
- ✅ Urinalysis (Normal/Abnormal with specification)
- ✅ Visit Date (Week 12 visit date)

### SECTION I – GLYCEMIC RESPONSE ASSESSMENT
- ✅ HbA1c Response Category:
  - ✅ Super-responder (↓ ≥1.5%)
  - ✅ Responder (↓ 1.0–1.49%)
  - ✅ Partial responder (↓ 0.5–0.99%)
  - ✅ Non-responder (<0.5%)
- ✅ AUTO-CALCULATED in outcomes-calculator.ts
- ✅ Exported to PDF and CSV

### SECTION J – WEIGHT, BP & RENAL OUTCOMES
- ✅ Weight change:
  - ✅ Loss ≥3 kg
  - ✅ Loss 1–2.9 kg
  - ✅ Neutral
  - ✅ Gain
- ✅ Blood pressure control achieved (Yes/No)
- ✅ Renal outcome:
  - ✅ Improved eGFR
  - ✅ Stable eGFR
  - ✅ Decline <10%
  - ✅ Decline ≥10%
- ✅ AUTO-CALCULATED in outcomes-calculator.ts

### SECTION K – ADHERENCE & TREATMENT DURABILITY
- ✅ Patient continuing KC MeSempa at Week 12? (Yes/No)
- ✅ If discontinued, reason:
  - ✅ Adverse event
  - ✅ Lack of efficacy
  - ✅ Cost
  - ✅ Patient preference
  - ✅ Other (free text)
- ✅ Missed doses in last 7 days (0 / 1–2 / 3–5 / >5)
- ✅ Any add-on / change in anti-diabetic therapy? (No/Yes with details)

### SECTION L – EVENTS OF SPECIAL INTEREST
- ✅ Hypoglycemia – mild
- ✅ Hypoglycemia – moderate
- ✅ Hypoglycemia – severe
- ✅ UTI
- ✅ Genital mycotic infection
- ✅ Dizziness / dehydration symptoms
- ✅ Hospitalization / ER visit (with reason specification)

### SECTION M – PHYSICIAN GLOBAL ASSESSMENT
- ✅ Overall efficacy (Excellent/Good/Moderate/Poor)
- ✅ Overall tolerability (Excellent/Good/Fair/Poor)
- ✅ Compliance (Excellent/Good/Fair/Poor)
- ✅ Would you prefer KC MeSempa for long-term therapy? (Yes/No)
- ✅ Patient profiles where KC MeSempa is preferred:
  - ✅ Uncontrolled T2DM
  - ✅ Obese T2DM
  - ✅ CKD patients
  - ✅ HTN + T2DM
  - ✅ Elderly patients

### SECTION N – PATIENT-REPORTED OUTCOMES
- ✅ Overall satisfaction with therapy (Very satisfied/Satisfied/Neutral/Not satisfied)
- ✅ GI tolerance vs prior therapy (Improved/Same/Worse)
- ✅ Patient confidence in managing diabetes (Improved/Same/Worse)
- ✅ Additional comments (optional)

---

## ⚠️ PARTIAL/INCOMPLETE IMPLEMENTATION

### SECTION L – SAFETY & ADVERSE EVENTS (GENERAL TABLE)
**Status**: Partial - Events of Special Interest implemented, but missing general adverse event table

**CRF Requirement**:
```
Adverse Event Details (MedDRA preferred term)
┌─────────┬─────────┬────────┬───────┬────────────┬─────────┐
│ AE Term │ Onset   │ Sever- │Serious│ Action     │ Outcome │
│         │ Date    │ity    │ Y/N   │ Taken      │         │
├─────────┼─────────┼────────┼───────┼────────────┼─────────┤
│         │ (MedDRA)│☐M/M/S │☐Y/N  │☐None/Dose/ │☐Resolved│
│         │         │        │       │  Stop/Ref  │☐Ongoing │
└─────────┴─────────┴────────┴───────┴────────────┴─────────┘
```

**What's Implemented**: 
- Type definition exists: `adverseEventsStructured` with aeTerm, onsetDate, severity, isSerious, actionTaken, outcome
- Not fully utilized in forms yet

**Recommendation**: Add general adverse event table entry form to allow physicians to document all adverse events with:
- AE Term (MedDRA preferred term)
- Onset Date
- Severity (Mild/Moderate/Severe)
- Is Serious (Yes/No)
- Action Taken (None/Dose adjusted/Drug stopped/Referred)
- Outcome (Resolved/Ongoing)

---

## ❌ NOT IMPLEMENTED

### SECTION O – DATA PRIVACY & CONFIDENTIALITY
**Status**: Missing from implementation

**CRF Content**:
- No personal identifiers recorded in this CRF
- Data collected as part of routine clinical practice
- Patient identity mapping retained only at clinic level

**Recommendation**: 
- Add as informational section in forms
- Checkbox: "I confirm this CRF contains no personal identifiers"
- Display privacy statements in patient data entry areas

---

### SECTION P – PHYSICIAN DECLARATION
**Status**: Missing from implementation

**CRF Content**:
- "I confirm that the above information is accurate and recorded as part of standard clinical practice."
- Physician Name
- Qualification
- Clinic / Hospital Name
- Signature & Stamp
- Date

**Recommendation**:
- Add physician declaration form section
- Fields:
  - Physician Name (auto-filled from logged-in doctor)
  - Qualification (auto-filled from doctor profile)
  - Clinic / Hospital Name (auto-filled from doctor.studySiteCode)
  - Signature (digital signature or checkbox for electronic signature)
  - Date (auto-filled with current date)
- Make this a required section before CRF submission

---

## Summary by Completion Level

| Level | Count | Items |
|-------|-------|-------|
| ✅ Fully Implemented | 13 | Sections A-N (all data fields) |
| ⚠️ Partial | 1 | Section L (Events of Special Interest done, general AE table pending) |
| ❌ Missing | 2 | Sections O & P (informational/signature sections) |

---

## Implementation Priority

### High Priority (Regulatory Requirement)
1. **SECTION L - Adverse Event Details Table** - Add general AE form with MedDRA terms
2. **SECTION P - Physician Declaration** - Add digital signature/certification section

### Medium Priority (Documentation)
1. **SECTION O - Privacy Statement** - Add informational section with checkboxes

---

## Code Locations

**Implemented Sections**:
- Type definitions: [lib/types.ts](lib/types.ts)
- Patient forms: [app/patients/add/page.tsx](app/patients/add/page.tsx) (SECTIONS A-E)
- Baseline form: [components/baseline-form.tsx](components/baseline-form.tsx) (SECTIONS F-G)
- Follow-up form: [components/followup-form-new.tsx](components/followup-form-new.tsx) (SECTIONS H-N)
- PDF/CSV export: [lib/pdf-export.ts](lib/pdf-export.ts) (All sections exported)

**Pending Implementation**:
- General Adverse Event form (SECTION L)
- Physician Declaration section (SECTION P)
- Privacy Statement section (SECTION O)

